Mpox in SA: stigma may be keeping people from coming forward, getting tested
South Africa might face an mpox (formerly monkeypox) outbreak as people may not come forward if they are infected for fear of stigmatisation. This is a warning by bioinformatician at the South African National Bioinformatics Institute, Peter van Heusden.
Heusden was reacting to the news this week that two more cases of mpox were reported in KwaZulu-Natal (KZN). This brings the total number of mpox cases in the country to four. Three of the cases are in KZN and one is in Gauteng.
According to health department spokesperson Foster Mohale, none of the patients diagnosed with mpox had any travel history to countries currently facing an outbreak of the disease.
Mohale says a preliminary case finding report shows two new cases in KZN had been in contact with the patient that was diagnosed a week prior.
“This suggests that there is local transmission of the disease which could lead to a larger outbreak in the province,” Mohale says.
Beyond that, Van Heusden, whose research focus is on the genomics of pathogens that cause infectious diseases, warns that the lack of a travel history outside the country among the cases reported suggests that there is some kind of local transmission happening but undetected.
“Mpox is a disease that is not as contagious as COVID-19 and will likely remain a very rare disease. The worst case scenario for mpox is that due to stigma and fear, people do not seek treatment and they also do not isolate themselves during the infectious period,” he explains.
“We know from other countries that mpox can sometimes present with milder symptoms,” he adds.
Mpox outbreaks
Mpox is an infectious disease caused by the monkeypox virus (MPXV). The virus is transmitted from one person to another by close contact with lesions, sexual contact, body fluids, respiratory droplets and contaminated materials such as bedding. Most people who get mpox fully recover while some get very sick.
Since January 2022 there’s been an ongoing multi-country outbreak of mpox with cases reported in all of the World Health Organisation’s (WHO) regions.
The Democratic Republic of Congo (DRC) reports the highest number of cases in the WHO’s Africa region. The country has been battling an mpox outbreak since 2023, that’s been driven by the monkeypox virus (MPXV) clade I.
The virus is classified into two clades. Clade I, identified as the Congo Basin clade, and clade II, formerly referred to as the West African clade.
Van Heusden says the 2022 global mpox outbreak was centred around men who have sex with men and featured what is known as clade IIb viruses. The mpox cases reported in South Africa feature this clade of the virus.
While there is a vaccine for mpox, it is not widely available due to the pricing policies of the company making it.
“It is also not likely to be needed urgently given how rare this disease is. The high pricing of this vaccine is still shameful though,” Van Heusden says.
Subscribe to our newsletter
Call to come forward
The department appeals to members of the public who have been in close contact with known or suspected patients of mpox to cooperate with health officials and present at the nearest health facility or healthcare provider.
“The health officials rely on transparency and cooperation from cases/patients for contact tracing and case finding in order to determine the rate of transmission of this infectious virus at community level,” says Mohale.
He says the department in collaboration with various stakeholders in the health sector is intensifying epidemiology and surveillance and also risk communication and community engagement activities.
“This will help to address social stigma which contributes to people’s decision not to openly speak out because they fear that they will not be accepted by their community. In most cases stigma contributes to the spread of the virus making the outbreak and transmission worse.” Health-e News
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Mpox in SA: stigma may be keeping people from coming forward, getting tested
by Yoliswa Sobuwa, Health-e News
June 7, 2024